Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Former FDA Commissioner Frank Young Passes Away At 88

Nov 26 2019

• By Michael Cipriano

Frank E Young Obituary — Former US FDA Commissioner Frank Young, 1931-2019

Related Content

SCRIPPS PRESIDENT CHARLES EDWARDS MAY RETURN TO FDA AS "INTERIM" HEAD; HARD-NOSED MANAGEMENT, TOP REPUTATION COULD HELP FDA THRU TOUGH TIMES

Nov 20 1989

BURROUGHS WELLCOME's RETROVIR WILL BE SHIPPED IN 2-3 WEEKS; DRUG WILL BE SHIPPED DIRECTLY TO PHARMACISTS ON A PATIENT BY PATIENT BASIS

Mar 30 1987

FDA ACCELERATED APPROVAL REG REQUIRES REPLICATION OF PHASE II FINDINGS; INTERIM RULE APPLIES TO TREATMENTS FOR LIFE-THREATENING, DEBILITATING ILLNESS

Oct 24 1988

Life After White Oak: Hamburg’s Predecessors Offer Glimpse At Where Pharma Might See Her Again

Feb 09 2015

Keeping Track: A Good Week For Biologics And Probuphine, Less So For Eteplirsen And ZS-9

May 30 2016

FDA Rejects Titan’s <em>Probuphine</em> Despite Positive Panel Vote

May 01 2013

Related Companies

Apple Tree Partners

Titan Pharmaceuticals Inc.

Additional Topics

United States FDA Leadership Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window